Patent: 5,602,116
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,602,116
Title: | Method for treating and preventing secondary hyperparathyroidism |
Abstract: | A method for preventing loss of bone mass or bone mineral content in a human being suffering from secondary hyperparathyroidism by administering a sufficient amount of 1.alpha.-OH vitamin D.sub.2, 1.alpha.,24(S)-(OH).sub.2 vitamin D.sub.2, 1.alpha.-OH vitamin D.sub.4 or 1.alpha.,24(R)-(OH).sub.2 vitamin D.sub.4. |
Inventor(s): | Knutson; Joyce C. (Madison, WI), Bishop; Charles W. (Verona, WI), Mazess; Richard B. (Madison, WI) |
Assignee: | Bone Care International, Inc. (Madison, WI) |
Application Number: | 08/415,488 |
Patent Claims: | see list of patent claims |
Details for Patent 5,602,116
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | See Plans and Pricing | 2014-02-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |